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Introduction
T helper-type 17 (Th17) cells are proinflammatory CD4+
cells characterized by Interleukin-17 (IL-17) production.
Evidence suggests cytokines produce by Th17s, including
IL-17, are involved in rheumatoid arthritis (RA) pathogen-
esis [1]. Lipopolysaccharide (LPS)-stimulated monocytes
promote CD4+ cell differentiation into Th17 cells, produ-
cing IL-17 in vitro[2].
Aim
Examine the effect of 4 anti–tumor necrosis factor (TNF)
agents (adalimumab, etanercept, infliximab, and certolizu-
mab pegol) on CD4+CD45RO+ memory T cell expansion
into Th17 cells, driven by LPS-stimulated monocytes.
Patients and methods
Monocytes and CD4+ cells were purified, by positive and
negative selection, from peripheral blood mononuclear
cells of healthy volunteers. CD4+CD45RO+ memory
T cells were enriched from the CD4+ cell fraction by posi-
tive selection. A 1:1 ratio of monocytes and memory
T cells was co-cultured for 7 days with CD3/CD28
Human T-Activator Dynabeads and 1 μg/mL LPS. Cells
were cultured with and without 10 μg/mL anti-TNF agent.
Subsequently, CD4+ cells were stained for intracellular
Interferon g (INFg) and IL-17A, and analyzed by flow cyto-
metry. IL-17A and IL-17F secretion was determined by
ELISA.
Results
IL-17A-producing CD4+ cell were 2.5-fold less frequent
in co-cultures with the 4 anti-TNF agents compared to
controls. IL-17A and IFNg producing CD4+ cell levels
were similar between the 4 anti-TNF agents. Compared
to controls, IL-17A and IL-17F secretion into the superna-
tant was lower in anti-TNF exposed co-cultures (580 pg/
mL vs. 180 pg/mL and 8 ng/mL vs. 2 ng/mL, respectively).
There were no significant differences in the IL-17A or
IL-17F concentration between co-cultures exposed to dif-
ferent anti-TNF agents.
Conclusion
Exposure to anti-TNF agents inhibited Th17 expansion
and IL-17A production, suggesting that anti-TNF agents
may reduce Th17 expansion and, as a consequence,
IL-17A and IL-17F concentration.
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